Identification of Predictive and Prognostic Markers for Lung Cancer With Metastases

Clinical trial NCT02301858 · UNKNOWN

Trial details

NCT number: NCT02301858
Sponsor: Janna Berg
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Lung Cancer Primary Tumor Metastases

Start date: 2013-12-01
Primary completion: 2025-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.